Dr. Peter Harper wrote what many people living with DM believe is the best lay overview of myotonic dystrophy in existence in a book entitled "The Facts: Myotonic Dystrophy."
Researchers have published several recent studies on advances in DM research.
Ionis Pharmaceuticals (formerly Isis Pharmaceuticals, Inc.) announced the identification of a drug development candidate, IONIS-DMPKRx, designed to treat Myotonic Dystrophy Type 1 (DM1), which they plan to advance into human clinical trials next year.
Researchers from the University of Rochester recently summarized the “diagnostic odyssey” experienced by a group of 814 individuals with myotonic dystrophy.
Timeline of key discoveries in myotonic dystrophy research since DM was first described in 1909.